Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://codeblue.galencentre.org/2022/10/31/cancer-drug-price-negotiations-to-focus-on-generics-biosimilars/
0
0
Cancer Drug Price Negotiations To Focus On Generics, Biosimilars - CodeBlue
10/31/22 at 4:10am
Organization
Galencentre.org
Author
CodeBlue
37 words
0
Comments
The UICC and WHO will negotiate for cheaper cancer drugs for low and low-middle-income countries via increased donations, tier pricing, or a voluntary licence mechanism.
Cancer
Pharmaceuticals & Biotech
Health Foundations & Medical Research
Drugs & Medications
Cancer Drug Price Negotiations
Biosimilars - CodeBlue
The UICC
licence mechanism
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...